SARS-CoV-2 variants and vulnerability at the global level

被引:96
作者
Chavda, Vivek P. [1 ]
Patel, Aayushi B. [2 ]
Vaghasiya, Darsh D. [2 ]
机构
[1] LM Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Ahmadabad 380009, Gujarat, India
[2] LM Coll Pharm, Pharm Sect, Ahmadabad, Gujarat, India
关键词
Delta plus variant; Delta variant; mutation; Omicron variant; SARS-CoV-2; vaccination; viral variant; OMICRON VARIANT; INFECTION; MUTATION; LINEAGE; GAMMA;
D O I
10.1002/jmv.27717
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity established with the existing COVID-19 vaccination. These variants are more transmissible, induce relatively extreme illness, have evasive immunological features, decrease neutralization using antibodies from vaccinated persons, and are more susceptible to re-infection. The Centers for Disease Control and Prevention (CDC) has categorized SARS-CoV-2 mutations as variants of interest (VOI), variants of concern (VOC), and variants of high consequence (VOHC). At the moment, four VOC and many variants of interest have been defined and require constant observation. This review article summarizes various variants of SARS-CoV-2 surfaced with special emphasis on VOCs that are spreading across the world, as well as several viral mutational impacts and how these modifications alter the properties of the virus.
引用
收藏
页码:2986 / 3005
页数:20
相关论文
共 153 条
[1]  
Aleem A, 2022, Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)
[2]   SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021 [J].
Alkhatib, Mohammad ;
Svicher, Valentina ;
Salpini, Romina ;
Ambrosio, Francesca Alessandra ;
Bellocchi, Maria Concetta ;
Carioti, Luca ;
Piermatteo, Lorenzo ;
Scutari, Rossana ;
Costa, Giosue ;
Artese, Anna ;
Alcaro, Stefano ;
Shafer, Robert ;
Ceccherini-Silberstein, Francesca .
MICROBIOLOGY SPECTRUM, 2021, 9 (03)
[3]  
Annavajhala M.K., 2021, NOVEL SAR COV 2 VARI, DOI [DOI 10.1101/2021.02.23.21252259, 10.1101/2021.02.23.21252259]
[4]  
[Anonymous], 2019, How the flu virus can change: "drift" and "shift"
[5]  
[Anonymous], 2021, Meduza
[6]   New viral vaccines [J].
Arvin, AM ;
Greenberg, HB .
VIROLOGY, 2006, 344 (01) :240-249
[7]  
Basu, 2022, CURR RES PHARM DRUG, V3, DOI 10.1016/j.crphar.2022.100086
[8]   Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Gallagher, Eileen ;
Simmons, Ruth ;
Thelwall, Simon ;
Stowe, Julia ;
Tessier, Elise ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin E. ;
Hopkins, Susan ;
Chand, Meera ;
Ramsay, Mary .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) :585-594
[9]  
Bharat Biotech, 2021, COVAXIN INDIAS 1 IND, V154, P1
[10]   Factor Influences for Diagnosis and Vaccination of Avian Infectious Bronchitis Virus (Gammacoronavirus) in Chickens [J].
Bhuiyan, Md Safiul Alam ;
Amin, Zarina ;
Abu Bakar, Ag Muhammad Sagaf ;
Saallah, Suryani ;
Yusuf, Noor Hydayaty Md ;
Shaarani, Sharifudin Md ;
Siddiquee, Shafiquzzaman .
VETERINARY SCIENCES, 2021, 8 (03)